The chitinase and chitinase-like proteins: A review of genetic and functional studies in asthma and immune-mediated diseases

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 5, 2009, Pages 401-408

  Ober, Carole ^a   Chupp, Geoffrey L ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid mammalian chitinase; CHI3L1; CHIA; CHIT1; Chitotriosidase; YKL 40

Indexed keywords

CHITINASE; CHITOTRIOSIDASE; PROTEIN; PROTEIN CHI3L1; PROTEIN CHIA; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ALLELE; ASTHMA; ATOPY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOLOGY; IMMUNOREGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ASTHMA; CHITINASE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GLYCOPROTEINS; HEXOSAMINIDASES; HUMANS; LECTINS; POLYMORPHISM, GENETIC;

EID: 69749119778     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283306533     Document Type: Review

References (63)

1. Lee CG, Da Silva CA, Lee JY, et al. Chitin regulation of immune responses: an old molecule with new roles. Curr Opin Immunol 2008; 20:684-689. Excellent comprehensive review of chitin effects on immune response. This review focuses on the conflicting studies of the pro-inflammatory or anti-inflammatory properties of chitin.
2. Wills-Karp M, Karp CL. Chitin checking: novel insights into asthma. N Engl J Med 2004; 351:1455-1457. (Pubitemid 39288173)
3. Fuhrman JA, Piessens WF. Chitin synthesis and sheath morphogenesis in Brugia malayi microfilariae. Mol Biochem Parasitol 1985; 17:93-104. (Pubitemid 15227842)
4. Kneipp LF, Andrade AF, de Souza W, et al. Trichomonas vaginalis and Tritrichomonas fetus: expression of chitin at the cell surface. Exp Parasitol 1998; 89:195-204. (Pubitemid 28380315)
5. Vogan CL, Costa-Ramos C, Rowley AF. Shell disease syndrome in the edible crab, Cancer pagurus: isolation, characterization and pathogenicity of chitinolytic bacteria. Microbiology 2002; 148:743-754. (Pubitemid 34232858)
6. Meibom KL, Li XB, Nielsen AT, et al. The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci U S A 2004; 101:2524-2529.
7. Pruzzo C, Vezzulli L, Colwell RR. Global impact of Vibrio cholerae interactions with chitin. Environ Microbiol 2008; 10:1400-1410. (Pubitemid 351670245)
8. Keyhani NO, Roseman S. Physiological aspects of chitin catabolism in marine bacteria. Biochim Biophys Acta 1999; 1473:108-122.
9. Bleau G, Massicotte F, Merlen Y, Boisvert C. Mammalian chitinase-like proteins. EXS 1999; 87:211-221.
10. Renkema GH, Boot RG, Strijland A, et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur J Biochem 1997; 244:279-285. (Pubitemid 27110727)
11. Renkema GH, Boot RG, Au FL, et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 1998; 251:504-509.
12. Shibata Y, Foster LA, Bradfield JF, Myrvik QN. Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J Immunol 2000; 164:1314-1321. (Pubitemid 30067244)
13. Shibata Y, Foster LA, Metzger WJ, Myrvik QN. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun 1997; 65:1734-1741. (Pubitemid 27193594)
14. Yan Z, Lambert NC, Guthrie KA, et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005; 118:899-906. (Pubitemid 41097469)
15. Boot RG, Blommaart EF, Swart E, et al. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 2001; 276:6770-6778. (Pubitemid 37373543)
16. Aguilera B, Ghauharali-van der Vlugt K, Helmond MT, et al. Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. J Biol Chem 2003; 278:40911-40916. (Pubitemid 37280911)
17. Zhu Z, Zheng T, Homer RJ, et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004; 304:1678-1682. (Pubitemid 38765861)
18. Reese TA, Liang HE, Tager AM, et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007; 447:92-96.
19. Lalaker A, Nkrumah L, Lee WK, et al. Chitin stimulates expression of acidic mammalian chitinase and eotaxin-3 by human sinonasal epithelial cells in vitro. Am J Rhinol Allergy 2009; 23:8-14. A recent study that examined the expression of AMCase in epithelial cells cultured from a human disease.
20. Ramanathan M Jr, Lee WK, Lane AP. Increased expression of acidic mammalian chitinase in chronic rhinosinusitis with nasal polyps. Am J Rhinol 2006; 20:330-335.
21. Bierbaum S, Nickel R, Koch A, et al. Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med 2005; 172:1505-1509. (Pubitemid 43076537)
22. Schoonhoven A, Rudensky B, Elstein D, et al. Monitoring of Gaucher patients with a novel chitotriosidase assay. Clin Chim Acta 2007; 381:136-139. (Pubitemid 46719145)
23. Kurt I, Abasli D, Cihan M, et al. Chitotriosidase levels in healthy elderly subjects. Ann N Y Acad Sci 2007; 1100:185-188. (Pubitemid 47092651)
24. Artieda M, Cenarro A, Ganan A, et al. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein. Cardiology 2007; 108:297-306. (Pubitemid 350126474)
25. Artieda M, Cenarro A, Ganan A, et al. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003; 23:1645-1652. (Pubitemid 37108211)
26. Grosso S, Margollicci MA, Bargagli E, et al. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest 2004; 64:57-62. (Pubitemid 38283210)
27. Bargagli E, Maggiorelli C, Rottoli P. Human chitotriosidase: a potential new marker of sarcoidosis severity. Respiration 2008; 76:234-238.
28. Seibold MA, Donnelly S, Solon M, et al. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. J Allergy Clin Immunol 2008, 122:944-950 e943. First characterization of true chitinases in the airway epithelial cells from asthmatic patients and smokers.
29. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993; 268:25803-25810. (Pubitemid 23358198)
30. Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006; 53:172-209.
31. Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury: analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993; 32:949-955.
32. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992; 7:501-512.
33. Kelleher TB, Mehta SH, Bhaskar R, et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 2005; 43:78-84. (Pubitemid 40805276)
34. Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer 2005; 48:223-231. (Pubitemid 40501811)
35. Johansen JS, Drivsholm L, Price PA, Christensen IJ. High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 2004; 46:333-340. (Pubitemid 39487308)
36. Johansen JS, Cintin C, Jorgensen M, et al. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 1995; 31A:1437-1442.
37. Schmidt K, Kraft HG, Parson W, Utermann G. Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon. Eur J Hum Genet 2006; 14:190-201. (Pubitemid 43135862)
38. Ostergaard C, Johansen JS, Benfield T, et al. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002; 9:598-604. (Pubitemid 34538220)
39. Kronborg G, Ostergaard C, Weis N, et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 2002; 34:323-326. (Pubitemid 34746248)
40. Nordenbaek C, Johansen JS, Junker P, et al. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis 1999; 180:1722-1726. (Pubitemid 29506483)
41. Brunak S, Engelbrecht J, Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 1991; 220:49-65. (Pubitemid 121004542)
42. Volck B, Johansen JS, Stoltenberg M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 2001; 9:203-214.
43. Matsumoto T, Tsurumoto T. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laboratory parameters. Clin Exp Rheumatol 2001; 19:655-660. (Pubitemid 34026828)
44. Fontana RJ, Goodman ZD, Dienstag JL, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008; 47:789-798.
45. Lee CG, Hartl D, Lee GR, et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med 2009; 206:1149-1166. The first study characterizing the phenotype of the YKL-40/BRP-30-knockout and airway-specific overexpression transgenic mice, showing that YKL-40 is a key regulator of apoptosis in Th2 inflammatory responses.
46. Chupp GL, Lee CG, Jarjour N, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007; 357:2016-2027. (Pubitemid 350106709)
47. Dickey BF. Exoskeletons and exhalation. N Engl J Med 2007; 357:2082-2084.
48. Canudas J, Cenarro A, Civeira F, et al. Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate. Metabolism 2001; 50:447-450. (Pubitemid 32321954)
49. Lee P, Waalen J, Crain K, et al. Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity. Blood Cells Mol Dis 2007; 39:353-360. (Pubitemid 47484470)
50. Malaguarnera L, Simpore J, Prodi DA, et al. A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions. Genes Immun 2003; 4:570-574. (Pubitemid 38961153)
51. Wright AF, Carothers AD, Pirastu M. Population choices in mapping for complex diseases. Nat Genet 1999; 23:397-404.
52. Bierbaum S, Superti-Furga A, Heinzmann A. Genetic polymorphisms of chitotriosidase in Caucasian children with bronchial asthma. Int J Immunogenet 2006; 33:201-204. (Pubitemid 43781723)
53. Lehrnbecher T, Bernig T, Hanisch M, et al. Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 2005; 19:1745-1750. (Pubitemid 41486151)
54. Freedman ML, Reich D, Penney KL, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004; 36:388-393. (Pubitemid 38437262)
55. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004; 36:512-517. (Pubitemid 38620038)
56. Zhao X, Tang R, Gao B, et al. Functional variants in the promoter region of chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 2007; 80:12-18. (Pubitemid 46047646)
57. Berres ML, Papen S, Pauels K, et al. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol 2009; 50:370-376. Interesting study supporting a role for a promoter variant in CHI3L1 and YKL-40 levels in the severity of liver fibrosis in chronic hepatitis C patients.
58. Ober C, Tan Z, Sun Y, et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008; 358:1682-1691. The first genome-wide association study of serum YKL-40 levels, identifying a promoter variant in CHI3L1 with a major effect on levels of this chitinase-like protein, and on asthma risk and lung function in European and European American populations. (Pubitemid 351549915)
59. Sohn MH, Lee JH, Kim KW, et al. Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 2009; 179:449-456. Identified a second functional promoter variant that was associated with atopic phenotypes in Koreans.
60. Kruit A, Grutters JC, Ruven HJ, et al. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 2007; 101:1563-1571. (Pubitemid 46832220)
61. Himes BE, Hunninghake GM, Baurley JW, et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 2009; 84:581-593.
62. Becker T, Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 2004; 27:21-32. (Pubitemid 38808342)
63. Seibold MA, Reese TA, Choudhry S, et al. Differential enzymatic activity of common haplotypic versions of the human acidic mammalian chitinase protein. J Biol Chem 2009 [Epub ahead of print]. Comprehensive survey of genetic variation in the CHIA gene in ethnically diverse populations. First study to demonstrate genotype effects on AMCase activity.